Report: No “Death Spiral” for ACA
An analysis from Standard & Poor’s found that the Affordable Care Act (ACA) may be healthier than previously thought. According to The New York Times, the report found that not only are insurers likely to break even this year, but most could see small profits in 2018. There are now signs that the market will be manageable for most insurers and is not in a so-called “death spiral.” This news came the same week that Wellmark Blue Cross and Blue Shield and Aetna said they would exit the Iowa exchange.
Minnesota Scraps State ACA Exchange
 Minnesota will move to the federally run health insurance exchange on January 1, 2019. A bill that passed the House would get rid of the state-run exchange, MNsure, which enrolled more than 100,000 Minnesotans this year, reported Post-Bulletin. With Minnesota moving to the federal exchange, there will only be 10 states and the District of Columbia still operating state-run exchanges under the ACA.
Curtailing Direct-to-Consumer Drug Ads
 America is one of just 2 developed countries that allow TV ads for prescription drugs, but that may change. According to STAT, Democrats want to make it less economically viable for companies to advertise directly to consumers, and Republicans may join the cause. The proposal being considered would force drug companies to pay taxes on advertising expenses–currently, they can write off those expenses.
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More